INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for scleroderma lung disease: major trial launches
Disease control Recruiting nowThis study tests new medicines for people with scleroderma who have lung scarring (interstitial lung disease). About 400 adults will receive either an experimental drug or a placebo for 52 weeks. The main goal is to see if the drugs help maintain or improve lung function, measure…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Phase: PHASE2 • Sponsor: Scleroderma Research Foundation, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Swedish scientists hunt for clues to stop scleroderma in its tracks
Knowledge-focused Recruiting nowThis study aims to uncover the key factors that cause and worsen systemic sclerosis (scleroderma), a serious autoimmune disease that hardens the skin and can damage organs like the lungs. Researchers will collect blood and skin samples from 150 patients in Sweden to look for gene…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC